Kimaritec is developing new therapies for cancer, by manipulating the body’s protein recycling pathway to drive protein degradation of critical oncoproteins. Cancer remains a disease with high unmet medical need, with many patients succumbing to tumours which become unresponsive to current therapy. ...See more
Headquarter Australia |
Year founded 2020 (4 years) |
Funding status Private |
Company type SME |